Search

Search Constraints

You searched for: Author/Creator Trotta, Anna Maria

Search Results

1. Aflibercept or bevacizumab in combination with FOLFIRI as second-line treatment of mRAS metastatic colorectal cancer patients: the ARBITRATION study protocol. (March 2021)

2. Disulfide Bond Replacement with 1, 4‐ and 1, 5‐Disubstituted [1, 2, 3]‐Triazole on C‐X‐C Chemokine Receptor Type 4 (CXCR4) Peptide Ligands: Small Changes that Make Big Differences. Issue 44 (20th July 2020)

3. Peptides targeting chemokine receptor CXCR4: structural behavior and biological binding studies†. (28th January 2014)

5. Rationale for combination of therapeutic antibodies targeting tumor cells and immune checkpoint receptors: Harnessing innate and adaptive immunity through IgG1 isotype immune effector stimulation. (February 2018)